Depakene is the trade name and generic name for sodium valproate extended-release tablets, which can cure epilepsy for 3 to 5 years in some patients with the medication, while others may need to take it for a long time to control their condition. The regression of epilepsy is mainly related to the patient’s condition. Sodium valproate extended-release tablets, a commonly used antiepileptic drug, is used for generalized epileptic seizures, cataplexy seizures, myoclonic seizures, tonic seizures, mixed seizures and so on. The condition of some patients can be effectively controlled after taking Sodium Valproate Extended-Release Tablets regularly, and clinical cure can be achieved after taking it for 3~5 years, with no seizures after gradual reduction and discontinuation of the drug. In some patients, epilepsy can be controlled after oral intake of Sodium Valproate Extended-Release Tablets, but epilepsy recurs after reducing or stopping the drug, so it needs to be taken for life. The common adverse reactions of sodium valproate extended-release tablets include nausea, diarrhea, epigastric pain, liver function abnormalities, etc. It is contraindicated if the patient suffers from acute hepatitis or chronic hepatitis. It is recommended that patients should take the medication as prescribed by the doctor and never adjust the dosage on their own to avoid seizures.